Source: Annual Congress 2003 - Clinical pathobiology in diffuse and in neoplastic disorders



Rating:

Share or cite this content

Citations should be made in the following way:
M. Dabrowska, H. Grubek-Jaworska, J. J. Domagala-Kulawik, G. Hoser, R. Krenke, P. Nejman, R. Chazan (Warsaw, Poland). Heterogeneous reactivity of ICAM-1 on alveolar macrophages (AMs) in patients with non-small cell lung cancer (NSCLC). Eur Respir J 2003; 22: Suppl. 45, 1687

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: Expression of macrophage migration inhibitory factor (MIF) in the serum and lung tissues in patients with non-small cell lung cancer (NSCLC) Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 Cytotoxicity and apotosis of alveolar lymphocytes (AL) in early clinical stage (I-IIa) of non-small cell lung cancer (NSCLC) Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018 Expression of the intercellular adhesion molecule ICAM-1 on alveolar macrophages in healthy subjects and non-small cell lung cancer patients Source: Eur Respir J 2002; 20: Suppl. 38, 276s Year: 2002 Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC Source: Eur Respir J 2005; 26: Suppl. 49, 92s Year: 2005 Role of chemokines in resectable non-small cell lung cancer (NSCLC) Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019 Role of EBUS-TBNA in the study of PD-L1 expression in patients with non-small cell lung cancer (NSCLC) Source: Virtual Congress 2020 – Endobronchial ultrasound: from rookie to pro Year: 2020 Tumour-associated macrophages in nonsmall cell lung cancer: the role of interleukin-10 Source: Eur Respir J 2007; 30: 608-610 Year: 2007 Gene expression profiles in non-small cell lung cancer (NSCLC) and lung tissue in smokers and non-smokers Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer Year: 2009 Cytotoxic phenotype of lymphocytes in bronchoalveolar lavage (BAL) of patients with non-small cell lung cancer (NSCLC) Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench Year: 2017 Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer Source: Eur Respir J 2007; 30: 627-632 Year: 2007 Relationship between blood monocyte subsets with activation markers and macrophages in non-small cell lung cancer Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020 Comparing exhaled molecular profiles of patients with non-small cell lung cancer (NSCLC) with those of patients with non-pulmonary malignancy Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 The prognostic influence of tumor infiltrating M1 and M2 phenotype macrophages in resected non-small cell lung cancer Source: International Congress 2016 – Lung cancer immunology: latest research Year: 2016 The influence of secondary infectious process on non-small cell lung cancer (NSCLC) patients survival Source: Eur Respir J 2007; 30: Suppl. 51, 280s Year: 2007 Characterization of patients with non-small cell lung cancer (NSCLC) relative to its EGFR mutational status Source: Annual Congress 2011 - Epidemiology of lung cancer and screening Year: 2011 TNFα as a prognostic factor in surgically treated non-small cell lung carcinomas Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005 24h-blood profile gene expression biomarkers of the response to bevacizumab-erlotinib (BE) in advanced non-squamous non-small cell lung cancer (NSCLC) Source: International Congress 2016 – Therapeutic trials in lung cancer Year: 2016 Investigation of survivin gene polymorphism in non-small cell lung cancer patients (NSCLC) Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 Differential cytokine expression in non-small cell lung carcinomas Source: Eur Respir J 2007; 30: Suppl. 51, 512s Year: 2007 Soluble non-invasive markers in non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 459s Year: 2005